Back to Results

An Open-Label, Randomized, Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Pegcetacoplan in the Treatment of Post-Transplant Recurrence of C3G or IC-MPGN

Study category: Kidney Disease & Hypertension

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Childrens Hospital Colorado
University of Colorado Hospital

Principal Investigator
Bradley Dixon,  MD

Bradley Dixon, MD

Study ID

Protocol Number: 20-2106

More information available at ClinicalTrials.gov: NCT04572854

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers